VANGL2 and central nervous system cancer: These findings suggest that Notch pathway activation counters the effects of VANGL2 knockdown on the viability and invasion of U-251 MG and T98G cells, indicating that VANGL2 may promote glioma cell proliferation and metastasis through Notch signaling activation.